RCE in Sourcecodester Drug Recommendation System
CVE-2026-105705
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This impacts an unknown function of the file Admin/add_drug.php. Performing a manipulation results in cross site scripting. The attack is possible to be carried out remotely. The exploit has been released to the public and may be used for attacks.
Vulnerability class: XSS (Cross-Site Scripting)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 4.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N.
EPSS exploit prediction
No EPSS score from FIRST.org yet. New CVEs usually get one within a few days; no score means no signal yet, not low risk. How EPSS works.
Affected products
- Sourcecodester Drug Recommendation System — versions 1.0
Weakness classification (CWE)
References
- vuldb.com/vuln/413698 (vdb-entry)
- vuldb.com/vuln/413698/cti (signature, permissions-required)
- vuldb.com/cve/CVE-2026-105705 (third-party-advisory)
- vuldb.com/submit/992054 (third-party-advisory)
- github.com/hackliu/Vulnerability-Reports/blob/master/Drug-Recommender-Web-App/V… (exploit)
- www.sourcecodester.com/ (product)
Frequently asked questions
- What is CVE-2026-105705?
- CVE-2026-105705 is a medium-severity vulnerability in Sourcecodester Drug Recommendation System, classified under Cross-site Scripting. CVSS score: 4.3/10. Published 2026-10-06.
- How severe is CVE-2026-105705?
- Medium severity. CVSS v3 base score is 4.3 out of 10.